WIP1 phosphatase is a negative regulator of NF-kappaB signalling

Area of Science:

• Molecular Biology
• Immunology
• Cell Signaling

Background:

• Kinases activating NF-kappaB are well-studied, but phosphatases that deactivate it remain largely unknown.
• NF-kappaB signaling is crucial for immune responses and inflammation, making its regulation a significant area of research.

Purpose of the Study:

• To identify phosphatases that negatively regulate NF-kappaB signaling.
• To elucidate the mechanism by which WIP1 phosphatase controls NF-kappaB activity and its role in inflammation.

Main Methods:

• Genome-scale siRNA screen to identify negative regulators of NF-kappaB.
• Biochemical assays to confirm direct dephosphorylation of NF-kappaB p65 subunit by WIP1.
• In vivo studies using knockout mice to assess the role of WIP1 in inflammation.

Main Results:

• WIP1 phosphatase was identified as a negative regulator of NF-kappaB signaling.
• WIP1 directly dephosphorylates Serine 536 on the NF-kappaB p65 subunit, inhibiting its transactivation function and p300 co-activator binding.
• WIP1 deficiency leads to enhanced NF-kappaB activation and increased inflammation in mice.

Conclusions:

• WIP1 is a direct phosphatase of NF-kappaB p65, acting as a critical negative regulator of this inflammatory pathway.
• The findings provide the first genetic evidence of a phosphatase directly controlling NF-kappaB signaling in vivo.
• Targeting WIP1 could offer new therapeutic strategies for inflammatory diseases.